Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023 16:05 ET
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
September 13, 2023 16:13 ET
|
Scinai Immunotherapeutics Ltd.
Scinai’s NanoAbs downregulated key molecular markers overexpressed in plaque psoriasis Stratum corneum regained normal appearance in laboratory 3D skin model Results from ex-vivo study...
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
September 11, 2023 08:17 ET
|
Evaxion Biotech
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine developmentEvaxion's AI model predicts vaccine efficacy in infectious disease modelsThese results...
Sandoz completes acquisition of leading antifungal agent Mycamine® from Astellas, reinforcing leading global anti-infectives portfolio
August 28, 2023 01:15 ET
|
Novartis Pharma AG
Sandoz completes acquisition of worldwide brand rights for Mycamine® (micafungin sodium) from Astellas Leading global echinocandin, one of three major antifungal classes, will significantly...
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 14, 2023 16:05 ET
|
Icosavax, Inc.
- Positive topline interim Phase 1 results for bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults - - Positive twelve-month immunogenicity data and initial proof-of-concept...
$2.34Bn Growth for Mice Model Market Size to Hit 5.4% CAGR with CRISPR Segment Driving Growth During 2022-2028
July 25, 2023 09:19 ET
|
The Insight Partners
Pune, India, July 25, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Mice Model Market Size Report and Forecast to 2028 - COVID-19 Impact and Global...
Generic Drugs Market to Reach $835.7 Billion, Globally, by 2032 at 8.1% CAGR: Allied Market Research
July 20, 2023 11:36 ET
|
Allied Market Research
Portland, OR, July 20, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Generic Drugs Market By Therapeutic Application (Cardiovascular, Infectious Diseases, Cancer,...
Viral Vector Production Market to reach $6.1 billion, Globally, by 2032 at 18.8% CAGR: Allied Market Research
July 13, 2023 09:31 ET
|
Allied Market Research
Portland, OR, July 13, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Viral Vector Production Market by viral vector type (Adenoviral Vectors, Lentiviral Vectors,...
Veterinary Reference Laboratory Market to surpass USD 12 billion by 2032, Says Graphical Research Powered by GMI
June 12, 2023 21:00 ET
|
Graphical Research
Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) -- Veterinary Reference Laboratory Market size will cross USD 12 billion by 2032. Increasing public-private investments in animal healthcare...
Global Sepsis Treatment Market likely to Cross USD 1.5 billion by 2031 along with a Moderate CAGR from 2021 to 2031: TMR study
June 09, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 09, 2023 (GLOBE NEWSWIRE) -- The global market for sepsis treatment was estimated to have reached a market valuation of around US$ 600 million in 2020. The...